Literature DB >> 9176195

Assessment of insulin sensitivity with minimal model: role of model assumptions.

A Mari1.   

Abstract

Insulin sensitivity is frequently assessed with the minimal model (MM) and the insulin-modified intravenous glucose tolerance test (MIVGTT). To ascertain the validity of this approach, the mechanisms by which the MM estimates glucose effectiveness and insulin sensitivity (SG and SI, respectively) from the data are analyzed theoretically. Published data and new labeled MIVGTTs in normal and non-insulin-dependent diabetic (NIDDM) subjects are used as reference data. One reason for the reported difficulty in estimating SI in NIDDM is the inadequacy of the MM to describe the data. SG is a biased estimate of the fractional glucose clearance (FGC) at basal insulin, and SI is a biased estimate of the average slope of the insulin concentration-FGC curve. The monocompartmental assumption and the role of glucose production in the MM are causes of bias. The bias is fairly constant across the spectrum of glucose tolerance (SG: approximately 150% overestimate; SI: approximately 30% underestimate). Also, SI is not expected to account satisfactorily for hepatic insulin sensitivity. Finally, by the use of SG and SI, FGC at a target insulin level (FGCMM) can be estimated. FGCMM agrees well with the analogous clamp index (difference 10%; correlation: r = 0.88, P < 0.002) and, in NIDDM, has a lower coefficient of variation than SI (57 vs. 82%). In conclusion, this analysis indicates that the MM is a sufficiently reliable method for the assessment of insulin sensitivity if it is used cautiously.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176195     DOI: 10.1152/ajpendo.1997.272.5.E925

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Comparison of equivalence and determination of diagnostic utility of min-mod and clamp methods for insulin resistance in diabetes free subjects: a meta-analysis.

Authors:  Antonio Gordillo-Moscoso; J Francisco Valadéz-Castillo; Peter B Mandeville; J Francisco Hernández-Sierra
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

Review 2.  Measurement of insulin resistance in chronic kidney disease.

Authors:  Hien Pham; Kristina M Utzschneider; Ian H de Boer
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-11       Impact factor: 2.894

3.  An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics.

Authors:  A Tura; S Sbrignadello; E Succurro; L Groop; G Sesti; G Pacini
Journal:  Diabetologia       Date:  2009-10-30       Impact factor: 10.122

4.  Pancreatic network control of glucagon secretion and counterregulation.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

5.  PharmML in Action: an Interoperable Language for Modeling and Simulation.

Authors:  R Bizzotto; E Comets; G Smith; F Yvon; N R Kristensen; M J Swat
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-09-15

Review 6.  Mathematical Modeling for the Physiological and Clinical Investigation of Glucose Homeostasis and Diabetes.

Authors:  Andrea Mari; Andrea Tura; Eleonora Grespan; Roberto Bizzotto
Journal:  Front Physiol       Date:  2020-11-25       Impact factor: 4.566

7.  Insulin sensitivity assessed by stable isotopes with oral glucose administration: validation with euglycaemic clamp.

Authors:  Leslie Bluck; Rachel Williams; Sarah Jackson; Burak Salgin; Carlo Acerini; David Dunger
Journal:  ISRN Endocrinol       Date:  2013-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.